Role of OSCAR Signaling in Osteoclastogenesis and Bone Disease
Open Access
- 12 April 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Formation of mature bone-resorbing cells through osteoclastogenesis is required for the continuous remodeling and repair of bone tissue. In aging and disease this process may become aberrant, resulting in excessive bone degradation and fragility fractures. Interaction of receptor-activator of nuclear factor-κB (RANK) with its ligand RANKL activates the main signaling pathway for osteoclastogenesis. However, compelling evidence indicates that this pathway may not be sufficient for the production of mature osteoclast cells and that co-stimulatory signals may be required for both the expression of osteoclast-specific genes and the activation of osteoclasts. Osteoclast-associated receptor (OSCAR), a regulator of osteoclast differentiation, provides one such co-stimulatory pathway. This review summarizes our present knowledge of osteoclastogenesis signaling and the role of OSCAR in the normal production of bone-resorbing cells and in bone disease. Understanding the signaling mechanism through this receptor and how it contributes to the production of mature osteoclasts may offer a more specific and targeted approach for pharmacological intervention against pathological bone resorption.Keywords
This publication has 130 references indexed in Scilit:
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- Meox2Cre-mediated disruption of CSF-1 leads to osteopetrosis and osteocyte defectsBone, 2012
- The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic jointsArthritis Research & Therapy, 2012
- OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and miceJCI Insight, 2011
- Cross-regulation of signaling by ITAM-associated receptorsNature Immunology, 2009
- NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubismJCI Insight, 2008
- Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethalityExperimental Hematology, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorptionThe Journal of cell biology, 2007
- Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patientsArthritis Research & Therapy, 2007